Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics is a research paper published in Pharmacological Reviews (2021). On theSindex it has a DataRank of 4.4. It has been cited 203 times, with 175 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.798
From this paper's citation signal
Citation Network Contribution
3.6
From 135 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 175 citers.
Novo Nordisk Fonden
Grant: NNF20SA0064201
Novo Nordisk Fonden
Grant: NNF20SA0063505
NIA NIH HHS
Grant: R01 AG060148
NIA NIH HHS
Grant: R21 AG061746
National Institutes of Health
Grant: 1R21AG061746-01
Modulating Polarization of Glial Cells in AD mouse models by a Complement Receptor Antagonist
National Institutes of Health
Grant: 5R01AG060148-04
Defining the Mechanistic Link between C5aR1 signaling and cognitive loss in Alzheimer's diseases
FWCI
9.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Increased infiltration of CD4+ T cell in the complement deficient lymphedema model
Additional file 1 of Increased infiltration of CD4+ T cell in the complement deficient lymphedema model
Additional file 2 of Increased infiltration of CD4+ T cell in the complement deficient lymphedema model
Additional file 2 of Increased infiltration of CD4+ T cell in the complement deficient lymphedema model